Visionary biotech leader with 27+ years of global experience driving innovation, growth, and patient impact across oncology, hematology, and cell & gene therapy. Proven CEO, board chair, and company builder with a track record of founding and scaling cutting-edge immuno-oncology platforms, securing strategic funding, building elite scientific teams, and delivering breakthrough therapeutics from concept to clinic. Combines scientific rigor with commercial acumen, leveraging dual MSc/MBA background to build differentiated strategies, forge investor confidence, and lead complex organizations through inflection points. Recognized for decisive leadership, cross-functional orchestration, and relentless focus on execution and value creation.